Laura K. Richman
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Viral Infectious Diseases and Gene Expression in Insects, Herpesvirus Infections and Treatments, Virus-based gene therapy research
Most-Cited Works
- → Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN(2018)770 cited
- → Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway(2011)404 cited
- → Type I Interferon: Potential Therapeutic Target for Psoriasis?(2008)307 cited
- → Neutralization of interferon‐α/β–inducible genes and downstream effect in a phase I trial of an anti–interferon‐α monoclonal antibody in systemic lupus erythematosus(2009)279 cited
- → Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology(2020)244 cited
- → Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study(2011)226 cited
- → Novel Endotheliotropic Herpesviruses Fatal for Asian and African Elephants(1999)215 cited
- → A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients(2013)165 cited
- → MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis(2015)144 cited
- → Inhibition of Myogenic MicroRNAs 1, 133, and 206 by Inflammatory Cytokines Links Inflammation and Muscle Degeneration in Adult Inflammatory Myopathies(2013)137 cited